These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 32783283)
1. Time-related biases in pharmacoepidemiology. Suissa S; Dell'Aniello S Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1101-1110. PubMed ID: 32783283 [TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroid use and the incidence of lung cancer in COPD. Suissa S; Dell'Aniello S; Gonzalez AV; Ernst P Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31744837 [TBL] [Abstract][Full Text] [Related]
3. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Suissa S Eur Respir J; 2004 Mar; 23(3):391-5. PubMed ID: 15065827 [TBL] [Abstract][Full Text] [Related]
4. Observational Studies of Inhaled Corticosteroid Effectiveness in COPD: Lessons Learned. Suissa S; Ernst P Chest; 2018 Aug; 154(2):257-265. PubMed ID: 29679596 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of early medication use for COPD: a population-based cohort study. Falk J; Dik N; Bugden S Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449 [TBL] [Abstract][Full Text] [Related]
6. The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach. Belleudi V; Di Martino M; Cascini S; Kirchmayer U; Pistelli R; Formoso G; Fusco D; Davoli M; Agabiti N; Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1295-1304. PubMed ID: 27396695 [TBL] [Abstract][Full Text] [Related]
7. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915 [TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD. Liu SF; Kuo HC; Liu GH; Ho SC; Chang HC; Huang HT; Chen YM; Huang KT; Chen KY; Fang WF; Lin MC Int J Chron Obstruct Pulmon Dis; 2016; 11():1607-14. PubMed ID: 27478374 [TBL] [Abstract][Full Text] [Related]
9. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD). Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882 [TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Long-Acting Beta Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405 [TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study. Suissa S; Dell'Aniello S; Ernst P Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028 [TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids in COPD and the risk of lung cancer. Lee YM; Kim SJ; Lee JH; Ha E Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812 [TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Kiri VA; Fabbri LM; Davis KJ; Soriano JB Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832 [TBL] [Abstract][Full Text] [Related]
14. Immortal time bias in pharmaco-epidemiology. Suissa S Am J Epidemiol; 2008 Feb; 167(4):492-9. PubMed ID: 18056625 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. Hurst JR; Dilleen M; Morris K; Hills S; Emir B; Jones R Int J Chron Obstruct Pulmon Dis; 2018; 13():781-792. PubMed ID: 29551894 [TBL] [Abstract][Full Text] [Related]
17. The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease. Souliotis K; Silva Miguel L; Hillas G; Borges M; Papageorgiou G; Viana D; Malhadeiro J; Soulard S Ther Adv Respir Dis; 2020; 14():1753466620926802. PubMed ID: 32519591 [TBL] [Abstract][Full Text] [Related]
18. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404 [TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Kiri VA; Pride NB; Soriano JB; Vestbo J Am J Respir Crit Care Med; 2005 Aug; 172(4):460-4. PubMed ID: 15901610 [TBL] [Abstract][Full Text] [Related]
20. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Blais L; Forget A; Ramachandran S Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]